Reference health

The evolving role of CD4 cell counts in HIV care

https://doi.org/10.1097/coh.0000000000000348
CiteStamped reference-health badge
38/38 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 38 checked references that resolve
resolves10.1186/s12981-016-0111-1
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
resolves10.1086/597262
Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
resolves10.1097/QAI.0b013e3182a39979
Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries
resolves10.1093/cid/ciu1137
Trends in CD4 Count at Presentation to Care and Treatment Initiation in Sub-Saharan Africa, 2002–2013: A Meta-analysis
resolves10.1001/jama.286.20.2568
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
resolves10.1371/journal.pmed.1001418
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
resolves10.1097/QAI.0000000000001092
Baseline CD4 Count and Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
resolves10.1371/journal.pone.0155256
POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis
resolves10.1016/S1473-3099(14)70896-5
The future role of CD4 cell count for monitoring antiretroviral therapy
resolves10.1056/NEJMoa1506816
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
resolves10.1056/NEJMoa1507198
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
resolves10.1097/COH.0b013e32835b8123
Scaling up antiretroviral therapy in resource-limited settings
resolves10.1056/NEJMoa1600693
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
resolves10.1172/JCI115494
Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.
resolves10.1086/510073
HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
resolves10.1016/S1473-3099(13)70073-2
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
resolves10.1136/bmj.d6884
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
resolves10.1093/cid/ciw117
Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies
resolves10.1097/QAD.0b013e3283560678
Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa
resolves10.1097/QAD.0000000000000236
Predicting treatment failure in adults and children on antiretroviral therapy
resolves10.1097/QAI.0b013e31824276e9
Prognostic Value of Virological and Immunological Responses After 6 Months of Antiretroviral Treatment in Adults With HIV-1 Infection in Sub-Saharan Africa
resolves10.7448/IAS.18.1.20061
CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta‐analysis
resolves10.1097/QAD.0b013e32835e0752
Adverse events associated with nevirapine use in pregnancy
resolves10.1371/journal.pmed.1002088
Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011–2013: Analysis of Annual Surveys at the Facility Level
resolves10.1097/QAI.0000000000001112
Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis
resolves10.1111/tmi.12746
Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy
resolves10.1016/S0140-6736(15)60164-7
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
resolves10.1097/QAD.0000000000000520
Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda
resolves10.1093/cid/ciu288
Advanced HIV Disease at Antiretroviral Therapy (ART) Initiation Despite Implementation of Expanded ART Eligibility Guidelines During 2007-2012 in Khayelitsha, South Africa
resolves10.1093/cid/ciu1138
<i>Editorial Commentary</i>: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care
resolves10.1016/S2352-3018(15)00137-X
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis
resolves10.1097/MD.0000000000002269
HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up
resolves10.1016/S1473-3099(16)30145-1
Changing epidemiology of HIV-associated cryptococcosis in sub-Saharan Africa
resolves10.1097/QAD.0000000000000658
The need for treatment interruption studies and biomarker identification in the search for an HIV cure
resolves10.1097/COH.0b013e3282f54cde
Treatment interruption as a tool to measure changes in immunologic response to HIV-1
resolves10.1097/QCO.0000000000000123
Advancing the HIV cure agenda
resolves10.1097/QAD.0000000000001005
CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy
resolves10.1111/hiv.12389
Reference curves for <scp>CD</scp>4 T‐cell count response to combination antiretroviral therapy in <scp>HIV</scp>‐1‐infected treatment‐naïve patients
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1097/coh.0000000000000348"><img src="https://citestamp.com/citestamped/10.1097/coh.0000000000000348/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1097/coh.0000000000000348/badge.svg)](https://citestamp.com/citestamped/10.1097/coh.0000000000000348)